Nutrition and Fitness Health Home>>Nutrition and Fitness>>Health news Written by: Kelly Roche, Ottawa Sun Sep. 6, 2013 From left, Dr. Duncan Stewart, lead principal investigator of the ENACT-AMI stem cell therapy trial, Harriet Garrow, who is part of a stem cell trial and her husband Peter Garrow during a press conference at the Ottawa Hospital General Campus September 5, 2013. (QMI Agency) OTTAWA -- A massive heart attack prompted Harriet Garrow to become the first patient participating in a groundbreaking clinical trial headquartered in the nation's capital. "I am thrilled to play a part in this research," said Garrow, 68, of Cornwall, Ont. Using a patient's own stem cells -- extracted from their blood shortly following a major heart attack -- to regenerate the damaged organ, Enhanced Angiogenic Cell Therapy-Acute Myocardial Infarction is a promising game-changer. Cells are enhanced then infused back into the patient's heart using special catheters. Stem cells have "incredible potential to repair and regenerate damaged organs," although cells from heart patients don't have the same healing abilities as those from healthy young adults, Stewart said. Whether the procedure is replacing damaged cells or helping damaged cells recover is anyone's guess. Nonetheless, "we know that if we … Continue reading →

People considering stem-cell treatment have been advised to think again, with six groups of medical specialists issuing a strong warning yesterday that unlicensed stem-cell treatments on offer could kill a patient. The medical societies that issued the statement include the Royal College of Physicians, the Dermatological Society, Heart Association of Thailand under the Royal Patronage of His Majesty the King, the Thai Society of Haematology, the Nephrology Society and the Neurology Society. The statement said the Medical Council of Thailand had only approved the use of stem-cell treatment on blood diseases - namely leukaemia, malignant lymphoma, aplastic anaemia, multiple myeloma and thalassemia. Clinical research on the use of stem-cell treatment is ongoing, but there is no scientific evidence that stem-cell therapy can effectively increasing a person's longevity, or delay organ degeneration or improve a patient's quality of life, Prof Kriang Tungsanga, president of the Royal College of Physicians, said. The move by the medical societies was prompted by widespread ads about stem-cell-based "miracle pills" that claim to ease the symptoms of chronic symptoms such as diabetes and heart disease. The unlicensed use of stem-cell therapy to treat heart disease, diabetes or for aesthetic purposes has become popular among celebrities and … Continue reading →

Durham, NC (PRWEB) September 06, 2013 A new study in the current issue of STEM CELLS Translational Medicine shows how a team of scientists led by Rex Moats, Ph.D., and Karen Aboody, M.D., discovered a safe, effective way to track the migration and distribution of neural stem cells used in treating invasive brain tumors. Their method, which involves pre-loading the cells before transplantation with ultra-small, super paramagnetic iron oxide nanoparticles that can then be detected via magnetic resonance imaging (MRI), has been approved for clinical trials in humans and has the potential to greatly accelerate the search for new treatments for deadly brain tumors and other diseases. Numerous stem cell-based therapies are currently under investigation, including an FDA-approved clinical trial focused on employing neural stem cells (NSCs) in delivering drugs targeting invasive brain tumors. The ability to monitor the time course, migration and distribution of stem cells following transplantation into these patients would provide critical information for optimizing treatment regimens, Dr. Moats said. However, no effective cell-tracking methodology had yet garnered clinical acceptance. A labeling and imaging protocol using clinical grade ferumoxytol an iron replacement product currently approved to treat iron deficiency anemia in patients with chronic kidney disease has … Continue reading →

Home Mail News Sports Finance Weather Games Groups Answers Flickr More omg! Shine Movies Music TV Health Shopping Travel Autos Homes Mobile Yahoo! News Search News Search Web Sign In Mail Help Account Info Help Suggestions Yahoo! Home Video Photos GMA Year in Review Odd Comics Travel Opinion Trending Now Who Knew? Weather The Upbeat U.S. U.S. Video GMA Education Religion Crimes and Trials Local Contributor Network Year In Review World World Video Middle East Europe Latin America Africa Asia Canada Australia/Antarctica Business Video Exclusives Today's Markets Stocks Personal Finance Marketplace Entertainment Video Clinton Concert Celebrity TV Movies Music Fashion Books Arts Theater Dear Abby Comics Odd News Sports Video NFL MLB NBA NCAAF NCAAB Soccer Cycling NHL Tennis Golf Boxing Motor Sports MMA Olympics Tech Gadgets Wireless Apple Social Media Security Open Source Gaming Apps This Could Be Big Upgrade Your Life Politics Remake America The Issues Women and Politics Press Releases Video Science Science Video Weather News Space / Astronomy Pets Dinosaurs / Fossils Biotech Energy Green Health Video Weight Loss Cancer Sexual Health Medications/Drugs Parenting/Kids Seniors/Aging Diseases/Conditions Blogs The Sideshow Katie's Take Power Players This Could Be Big Newsmakers Trending Now The Upbeat Who Knew? Nightline Fix … Continue reading →

SAN ANTONIO--(BUSINESS WIRE)-- America Stem Cell, Inc. (ASC) announced today it has received clearance from FDA for its Phase I/IIa nationwide multi-center dual-umbilical cord transplantation study evaluating ASC-101 in patients with hematologic malignancies and myelodysplastic syndrome. ASC-101 is currently undergoing evaluation in a single-center study at The University of Texas MD Anderson Cancer. To date, 12 patients have been enrolled in the study with 9 patients evaluable. On the basis of data obtained in the single-center study, FDA has given approval to proceed with a multi-center trial. Enhancing umbilical cord stem cell engraftment into bone marrow in the dual cord transplant setting will improve clinical outcomes for patients with serious, life-threatening cancers and other disorders for which hematopoietic stem cell transplant is prescribed, said, Dr. Elizabeth Shpall, MD, Medical Director, Cell Therapy Laboratory and Director, Cord Blood Bank at M.D. Anderson Cancer Center and Study Chair on the ASC-101 Phase I/IIa clinical trial. Dr. Shpall has submitted an abstract to the upcoming American Society of Hematology (ASH) meeting in December describing the clinical results to date with ASC-101. There is a significant unmet medical need to improve stem cell engraftment into bone marrow for patients undergoing umbilical cord transplantation, and … Continue reading →

Featured Article Academic Journal Main Category: Epilepsy Also Included In: Sports Medicine / Fitness Article Date: 05 Sep 2013 - 0:00 PDT Current ratings for: Epilepsy risk for men reduced with exercise 5 (1 votes) Young male adults who exercise vigorously could reduce their risk of developing epilepsy later in life, according to a study published online in the journal Neurology. Researchers from Sweden analyzed the fitness of 1.17 million Swedish military servicemen, who were required to carry out cycle tests that measured their cardiovascular fitness when they enlisted for service at the age of 18. The participants were then assessed for the prevalence of epilepsy for an average of 25 years. During this period, 6,796 men were diagnosed with the condition. Epilepsy is a brain disorder that causes recurring seizures as a result of abnormal electrical activity in the brain. According to the Centers for Disease Control and Prevention (CDC), around 2 million people in the US currently suffer from the disease. The findings of this study revealed that young men who had a high level of fitness were 79% less likely to develop epilepsy later in life, compared with young men with low fitness levels. Additionally, compared with … Continue reading →

Carrollton, TX (PRWEB) September 05, 2013 When concerns about a childs development arise and autism is suspected, parents and caregivers turn to experts for help. Many parents contact their school district, their childrens physician or look into therapeutic treatments. The road to success for children at risk for autism is often paved by early diagnosis and treatment. With autism on the rise it is more important than ever to seek help early for those at risk. Teach Me llc in Dallas Texas has recently expanded services in Houston, Tulsa and Denver, Colorado to meet the growing need. Specializing in research based, comprehensive evaluations necessary to make an educational diagnosis, their team of licensed behavioral professionals work to bring each child to their full potential. Autism Spectrum Disorder, ASD, represents a broad range of complex neurodevelopment disorders and although there is no definitive test to confirm a diagnosis, understanding the difference between an educational diagnosis and medical diagnosis of ASD can be helpful to parents navigating resources. An Educational Determination of ASD is made by a multidisciplinary evaluation team, comprised of a variety of educational professionals. Along with parent interviews, comprehensive evaluations are conducted to determine the childs eligibility for special … Continue reading →